“Natt, Neena”的搜索结果，显示 81-90 项，共有 1054 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The aim of the study is to create a registry to prospectively collect pre-operative, during surgery and post-operative data, questionaries will assess (at ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

4. α1抗胰蛋白酶缺乏症- 症状与病因- 妙佑医疗国际

   In the lungs, a lack of AAT protein can lead to emphysema or ongoing bronchitis. These are forms of chronic obstructive pulmonary disease (COPD). The lack of ...

5. 乳腺癌- 医生与科室- 妙佑医疗国际

   了解这种常见的癌症，包括有关预防、症状、诊断和治疗的信息。

6. 乳腺癌- 医生与科室- 妙佑医疗国际

   了解这种常见的癌症，包括有关预防、症状、诊断和治疗的信息。

7. 胃肠道出血- 医生与科室- 妙佑医疗国际

   显示$起始范围- $结束范围/源自可用$可用医生. Neena S. ... Abraham, Neena S. M.D.. Arizona. Alexander, Jeffrey A. M.D.. Minnesota. Bruining ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Effective treatments for recurrent gynecological cancer are lacking, and there is a need for novel therapeutic options. One of the barriers to improving ...

9. 乳腺癌- 医生与科室- 妙佑医疗国际

   了解这种常见的癌症，包括有关预防、症状、诊断和治疗的信息。

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...